Bradycardia

Revision as of 20:17, 24 April 2009 by Umert (talk | contribs)
Jump to navigation Jump to search
Bradycardia
ICD-10 R00.1
ICD-9 427.81, 659.7, 785.9, 779.81

WikiDoc Resources for Bradycardia

Articles

Most recent articles on Bradycardia

Most cited articles on Bradycardia

Review articles on Bradycardia

Articles on Bradycardia in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Bradycardia

Images of Bradycardia

Photos of Bradycardia

Podcasts & MP3s on Bradycardia

Videos on Bradycardia

Evidence Based Medicine

Cochrane Collaboration on Bradycardia

Bandolier on Bradycardia

TRIP on Bradycardia

Clinical Trials

Ongoing Trials on Bradycardia at Clinical Trials.gov

Trial results on Bradycardia

Clinical Trials on Bradycardia at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Bradycardia

NICE Guidance on Bradycardia

NHS PRODIGY Guidance

FDA on Bradycardia

CDC on Bradycardia

Books

Books on Bradycardia

News

Bradycardia in the news

Be alerted to news on Bradycardia

News trends on Bradycardia

Commentary

Blogs on Bradycardia

Definitions

Definitions of Bradycardia

Patient Resources / Community

Patient resources on Bradycardia

Discussion groups on Bradycardia

Patient Handouts on Bradycardia

Directions to Hospitals Treating Bradycardia

Risk calculators and risk factors for Bradycardia

Healthcare Provider Resources

Symptoms of Bradycardia

Causes & Risk Factors for Bradycardia

Diagnostic studies for Bradycardia

Treatment of Bradycardia

Continuing Medical Education (CME)

CME Programs on Bradycardia

International

Bradycardia en Espanol

Bradycardia en Francais

Business

Bradycardia in the Marketplace

Patents on Bradycardia

Experimental / Informatics

List of terms related to Bradycardia

Cardiology Network

Discuss Bradycardia further in the WikiDoc Cardiology Network
Adult Congenital
Biomarkers
Cardiac Rehabilitation
Congestive Heart Failure
CT Angiography
Echocardiography
Electrophysiology
Cardiology General
Genetics
Health Economics
Hypertension
Interventional Cardiology
MRI
Nuclear Cardiology
Peripheral Arterial Disease
Prevention
Public Policy
Pulmonary Embolism
Stable Angina
Valvular Heart Disease
Vascular Medicine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Bradycardia, as applied to adult medicine, is defined as a resting heart rate of under 60 beats per minute, though it is seldom symptomatic until the rate drops below 50 beat/min. [1] Trained athletes tend to have slow resting heart rates, and resting bradycardia in athletes should not be considered abnormal if the individual has no symptoms associated with it.

The term relative bradycardia is used to explain a heart rate that, while not technically below 60 beats per minute, is considered too slow for the individual's current medical condition.

This cardiac arrhythmia can be underlain by several causes, which are best divided into cardiac and non-cardiac causes. Non-cardiac causes are usually secondary, and can involve drug use or abuse; metabolic or endocrine issues, especially in the thyroid; an electrolyte imbalance; neurologic factors; autonomic reflexes; situational factors such as prolonged bed rest; and autoimmunity. Cardiac causes include acute or chronic ischemic heart disease, vascular heart disease, valvular heart disease, or degenerative primary electrical disease. Ultimately, the causes act by three mechanisms: depressed automaticity of the heart, conduction block, or escape pacemakers and rhythms.

Causes

There are generally two types of problems that result in bradycardias: disorders of the sinus node, and disorders of the atrioventricular node (AV node).

With sinus node dysfunction (sometimes called sick sinus syndrome), there may be disordered automaticity or impaired conduction of the impulse from the sinus node into the surrounding atrial tissue (an "exit block"). It is difficult and sometimes impossible to assign a mechanism to any particular bradycardia, but the underlying mechanism is not clinically relevant to treatment, which is the same in both cases of sick sinus syndrome: a permanent pacemaker.

Atrioventricular conduction disturbances (aka: AV block; 1o AV block, 2o type I AV block, 2o type II AV block, 3o AV block) may result from impaired conduction in the AV node, or anywhere below it, such as in the bundle of HIS.

Patients with bradycardia have likely acquired it, as opposed to having it congenitally. Bradycardia is more common in older patients.

Complete Differential Diagnosis of the Causes of Bradycardia

(In alphabetical order)


Complete Differential Diagnosis of the Causes of Bradycardia

(By organ system)

Cardiovascular Atrioventricular Block,Cardiac arrhythmia,

Cardiac Dysrhythmias, Cardiomegaly, Right Bundle Branch Block, Second Degree AV Block, ST Elevation Myocardial Infarction Complications, Sinoatrial Block, Pulseless ventricular tachycardia, Sick sinus syndrome,


Chemical / poisoning No underlying causes
Dermatologic No underlying causes
Drug Side Effect

Aceclidine, Acepromazine, Acetylcholinesterase inhibitor, Adenosine, Amiodarone, Amodiaquine, Atenolol, Barbiturates, Beta-blockers, Bupivacaine, Calcium channel blocker, Clomipramine, Detomidine, Digitalis, Diltiazem, Diphenhydramine, Donepezil, Doxepin, Glyceryl trinitrate , Hydrocodone, Ibuprofen, Isosorbide dinitrate, Ivabradine, Levobetaxolol, Levobupivacaine, Lidocaine, Lithium, Medetomidine, Mefloquine, Mepivacaine, Methacholine, Methoxamine, Methyldopa, Morphine, Moxonidine, Nadolol, Nalbuphine, Nalmefene, Opioid, Oxymorphone, Phenobarbital, Phenylephrine, Phenytoin, Pilocarpine, Propafenone, Propranolol, Quinidine, Reserpine, Ropivacaine, Sulpiride, Suxamethonium chloride, Tacrine, Timolol, Trazodone, Uncaria tomentosa, Xylazine,

Ear Nose Throat No underlying causes
Endocrine Hypothyroidism,
Environmental Grayanotoxin,

Hellebore, Hypothermia,


Gastroenterologic No underlying causes
Genetic Congenital Long QT Syndrome,

Catecholaminergic polymorphic ventricular tachycardia, Emery-Dreifuss muscular dystrophy,


Hematologic No underlying causes
Iatrogenic

Enema, Gastric lavage, PCI Complications: Radiocontrast toxicity, Rapid sequence induction,


Infectious Disease Chagas' disease,

Hantavirus pulmonary syndrome, Legionella pneumonia and Mycoplasma pneumonia, Tularaemia, Colorado tick fever, Brucellosis, Trypanosoma cruzi, Typhoid fever,



Musculoskeletal / Ortho Holt-Oram syndrome,

Vertebral subluxation,


Neurologic Vasovagal syncope,

Vagal episode, Neurogenic shock, Subarachanoid hemorrhage, Raised Intracranial pressure, Autonomic neuropathy, Cerebral hemorrhage, Cerebral venous sinus thrombosis, Cushing triad, Cushing reaction, Cushing reflex, Neurocardiogenic Syncope,



Nutritional / Metabolic Hypercalcemia,

Hyperkalemia, Hypokalemia, Anorexia Nervosa,


Obstetric/Gynecologic Fetal distress,

Neonatal lupus erythematosus, Vasa previa,


Oncologic No underlying causes
Opthalmologic Oculocardiac reflex,
Overdose / Toxicity Gamma-Hydroxybutyric acid,

Hydroxyethyl starch Speedball (drug), Theobromine poisoning,

Psychiatric Anorexia Nervosa,
Pulmonary Apnea of prematurity,
Renal / Electrolyte No underlying causes
Rheum / Immune / Allergy No underlying causes
Sexual No underlying causes
Trauma No underlying causes
Urologic No underlying causes
Miscellaneous Drowning,

Mammalian diving reflex,


Management

There are two main reasons for treating any cardiac arrhythmias. With bradycardia, the first is to address the associated symptoms, such as fatigue, limitations on how much an individual can physically exert, fainting (syncope), dizziness or lightheadedness, or other vague and non-specific symptoms. The other reason to treat bradycardia is if the person's ultimate outcome (prognosis) will be changed or impacted by the bradycardia. Treatment in this vein depends on whether any symptoms are present, and what the underlying cause is. Primary or idiopathic bradycardia is treated symptomatically if it is significant, and the underlying cause is treated if the bradycardia is secondary.

Treatment

Drug treatment for bradycardia is typically not indicated for patients who are asymptomatic. In symptomatic patients, underlying electrolyte or acid-base disorders or hypoxia should be corrected first. IV atropine may provide temporary improvement in symptomatic patients, although its use should be balanced by an appreciation of the increase in myocardial oxygen demand this agent causes.

Atropine 0.5-1 mg IV or ET q3-5min up to 3 mg total (0.04 mg/kg)

See also

References

Template:Skin and subcutaneous tissue symptoms and signs Template:Nervous and musculoskeletal system symptoms and signs Template:Urinary system symptoms and signs Template:Cognition, perception, emotional state and behaviour symptoms and signs Template:Speech and voice symptoms and signs Template:General symptoms and signs

Template:SIB

de:Bradykardie it:Bradicardia nl:Bradycardie nn:Bradykardi sk:Bradykardia sv:Bradykardi


Template:WikiDoc Sources